Agilisium and Sri Ramachandra Institute of Higher Education and Research (SRIHER) forge a Strategic Partnership to Launch India’s First Agentic AI-Powered Digital Health & Research Centre
Chennai, 21st July, 2025: In a landmark move that positions India at the forefront of life sciences and healthcare innovation, Agilisium, a leading autonomous Agentic AI partner to the life sciences industry, has signed a Memorandum of Understanding (MoU) with the prestigious Sri Ramachandra Institute of Higher Education and Research (SRIHER) to establish the country’s firstAgentic AI-Powered Digital Health & Research Centre. Dedicated to advancing scientific research, healthcare delivery, and academic excellence through AI and GenAI, the Centre will serve as a collaborative hub to drive breakthroughs in precision medicine, digital diagnostics, and data-driven clinical research. By combining Agilisium’s expertise in AI-driven solutions with SRIHER’s clinical and academic leadership, the Centre aims to develop next-generation diagnostic tools, intelligent decision-support systems, and interoperable health data frameworks, positioning India as a global leader in future-ready digital healthcare.
The collaboration aims to harness powerful synergies between clinical expertise and technology innovation to address some of the most critical challenges in modern healthcare. Agilisium will contribute its deep capabilities in advanced analytics, data science, biostatistics, GenAI, and autonomous Agentic AI, while SRIHER will provide access to rich clinical datasets, domain specialists, and advanced medical facilities and expertise. A major thrust of the partnership will be on co-developing and publishing high-impact scientific research that spans AI-powered clinical trials, predictive diagnostics, and personalized medicine; efforts that will significantly raise the bar for healthcare and life sciences R&D in India.
The AI-led interventions pioneered by this partnership will incubate cutting-edge solutions in clinical decision-making, digital diagnostics, and hospital efficiency. Avenues for development of intelligent decision-support tools, digital twins to simulate personalized treatments, and smart hospital infrastructure powered by AI and IoT will open up. Predictive analytics to support disease surveillance and early intervention, enabling hospitals and policymakers to respond proactively to emerging health challenges will be a distinct contribution.
In a bid to transform India’s digital health ecosystem, the two institutions will work together on a large-scale Clean Health Data Initiative, aimed at improving the quality, standardization, and interoperability of both structured and unstructured medical data. Agilisium will deploy advanced AI tools for data cleansing, standardization, and governance, ensuring datasets are compliant with global healthcare regulations and research-ready. SRIHER will support this by offering blinded access to clinical records to pilot AI tools in real-world settings.
This partnership will not only address technology and research but will aid in the growing demand for intelligent, scalable patient care tools. AI-powered chatbots and GenAI-enabled virtual assistants to support clinicians, patients, and caregivers with real-time diagnostics, documentation, and remote monitoring will be the tools developed, piloted and validated at SRIHER’s hospital environment to measure clinical impact and user experience.
The MoU also outlines the development of an industry-first academic certification program on Generative AI in Healthcare. Jointly designed and delivered by Agilisium and SRIHER, the course will cover applications across drug discovery, diagnostics, predictive modeling, and patient care. While Agilisium will offer real-world technology expertise, SRIHER will embed clinical relevance and academic rigor into the curriculum. Together, they aim to build a future-ready talent pool equipped to lead AI innovation in the healthcare sector.
The partnership will also explore collaborations such as joint workshops, seminars, conferences and CSR-driven research funding to support socially relevant healthcare innovations.
Speaking on the partnership, Raj Babu , CEO of Agilisium, said, “This partnership marks a defining moment in our mission to transform life sciences and healthcare through Agentic AI. By joining forces with SRIHER, we are laying the foundation for a future-ready ecosystem - one that brings synthetic workforce (AI Agents) and AI-native talent together to solve the most pressing challenges in the industry. India’s AI revolution won’t be 100% imported - it will be co-created. Through this initiative, and deep STEM collaborations, we are activating India’s research and data commons to spark breakthrough innovations especially in patient care. This Centre embodies our commitment to reimagining how life sciences and healthcare organizations operate, with AI-engineered business processes that are autonomous, scalable, and built for the next era.”
Echoing this sentiment, Dr. Uma Sekar, Vice Chancellor of SRIHER, remarked, “This MoU aligns perfectly with our mission to integrate science, education, and technology for the betterment of patient care. With Agilisium’s AI expertise, we can push the boundaries of what’s possible in digital health to improve patient outcomes and experience. This MoU signals a shared commitment to using the power of technology and human insight to create a healthier, smarter, and more equitable future.
About Agilisium - Agilisium is the only leading Autonomous Agentic AI partner for the Life Sciences industry. The company delivers cutting-edge solutions that drive impactful change by combining strong domain expertise with GenAI, Autonomous Agentic AI and Advanced Analytics. Agilisium collaborates with leading pharma and biotech companies to provide hyper automation of mission-critical business processes, data-driven insights, and innovative solutions across the value chain, helping accelerate drug discovery, optimize patient care, achieve commercial success, streamline product delivery, and foster collaboration. The company’s commitment to rigorous execution and continuous innovation enables it to shape the future of the Life Sciences industry.
About Sri Ramachandra Institute of Higher Education and Research (SRIHER)
Sri Ramachandra Institute of Higher Education and Research is a leading Institution and is one of the top ranked Universities in the country engaged in the education and health care sector. With a reputation for delivery of quality health care for over four decades, SRIHER is at the forefront of Research, Education and Service excellence in health care.
SRIHER’s has been laying thrust on research driven by interdisciplinary thematic clusters that cover medical, allied health, technology, and social sciences. These clusters of research progression have catalyzed innovation bringing in numerous patents, copyrights and commercial products. SRIHER is home to 121 patents (filed 30, published 55 and granted 36) and 62 copyrights. The research endeavors receive funding from agencies like DBT, DST, SERB, ICMR, ICSSR and DHR, as well as global entities such as the NIH (USA), Wellcome Trust, NIHR (UK), and the Bill & Melinda Gates Foundation.
In a significant stride towards translational innovation, SRIHER houses a BIRAC-DBT-funded incubation ecosystem, nurturing 60 high-potential start-ups across diverse domains - digital health, point-of-care diagnostics, educational technology, clean energy, and medical devices.
SRIHER continues to transform education, healthcare, and research through quality in education, innovation, excellence.
